Shown solid blue (Tier 1) on the CMS 2025 OPO Tier Status map based on 2023 performance data; OPO name and code INOP confirmed in the document's OPO code table.
This OPO is graded Tier 1 (2025 (data year 2023)) under the CMS Conditions for Coverage outcome measures. Tier 1 is the top-performing band, automatically recertified.
Senate Finance memo: anonymous complaint that an OR team opened a donor while the heart was still beating
Indiana Donor Network
The Senate Finance Committee's 2022 hearing staff memo documented, as one of its illustrative DCD cases, an anonymous complaint submitted to UNOS on February 24, 2017 alleging that when the operating-room team opened the donor surgically, the donor's heart was still beating, and death was not declared until 10 minutes later. The memo states the underlying complaint is on file with the Committee.
Individual OPOs self-reported pancreata-for-research increases ranging from 10% to 6,400% in a single year (2021-2022)
Donor Alliance; Lifebanc; Indiana Donor Network; OneLegacy; Texas Organ Sharing Alliance; and other surveyed OPOs
In responses cited by the Senate Finance Committee 'Operation Transplant' report, OPOs reported widely varying single-year (2021-2022) increases in pancreata placed for research: Donor Alliance reported a 6,400% increase, Lifebanc 2,000%, Indiana Donor Network 747%, Lifeline of Ohio 392%, OneLegacy 390%, LifeQuest 267%, Texas Organ Sharing Alliance 216%, Mid-America Transplant 56%, NJ Sharing Network 89%, and Kentucky Organ Donor Affiliates 10%. The report flags these increases as evidence of possible gaming of CMS performance metrics.
Every item is institution-level public record, source-linked; no patient, donor, or family is named. A Tier or finding here repeats the government's own assessment of an organization holding a public monopoly. Back to OrganWatch.